Vendor, Palo Alto, CA, part of Ascendis Pharma Inc.
Ascendis Pharma, Inc.
UEI UKN2MTNJ9WM5, CAGE 88T95
3 awards and $210,118 obligated between June 11, 2024 and August 27, 2026, 100% under full and open competition, against 333.7 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $210,118 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
| Delivery Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36C26025F0329Delivery Order, July 15, 2025, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Yorvipath 168MCG Inj,soln,penNAICS 325412, PSC 6505 | $210,118 |
| 36E79725A0003February 3, 2025, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for YorvipathNAICS 325412, PSC 6505 | $0 |
| 36F79722D0166June 11, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | FSSNAICS 325412, PSC 6505 | $0 |
- Places of performance
- Pennsylvania
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 25 across 3 awards